Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Enveric Biosciences Inc (ENVB)

Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Enveric Biosciences Inc 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142 USA

www.enveric.com Employees: 6 P: 239-302-1707

Sector:

Medical

Description:

Enveric Biosciences Inc. is a patient-centric biotechnology company endeavoring to enhance the lives of Cancer Treatments with novel cannabinoid medicines. Enveric Biosciences Inc., formerly known as AMERI Holdings Inc., is based in NAPLES, Fla.

Key Statistics

Overview:

Market Capitalization, $K 2,340
Enterprise Value, $K 100
Shares Outstanding, K 597
Float, K 594
% Float 99.44%
Short Interest, K 114
Short Float 19.00%
Days to Cover 1.00
Short Volume Ratio 0.64
% of Insider Shareholders 0.56%
% of Institutional Shareholders 13.82%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -9,570 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,870 K
EBIT, $ -9,510 K
EBITDA, $ -9,170 K

Growth:

1-Year Return -93.78%
3-Year Return -99.22%
5-Year Return -99.99%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 99.78%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -10.81 on 11/14/25
Next Earnings Date 03/27/26
Earnings Per Share ttm -37.11
EPS Growth vs. Prev Qtr 7.17%
EPS Growth vs. Prev Year 74.97%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 10/28/25

ENVB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -349.10%
Return-on-Assets % -241.89%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.61
Book Value/Share 6.65
Interest Coverage -0.48
60-Month Beta 0.30
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar